Oleg Nodelman - Feb 19, 2023 Form 4 Insider Report for Nuvation Bio Inc. (NUVB)

Role: Director
Signature: Oleg Nodelman, individually and as Manager of EcoR1 Capital, LLC and Biotech Opportunity GP, LLC
Stock symbol: NUVB
Transactions as of: Feb 19, 2023
Transactions value $: $6,692,265
Form type: 4
Date filed: 9/21/2023, 08:08 PM
Previous filing: Nov 2, 2021
Next filing: Sep 22, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NUVB	Class A Common Stock	Purchase	$6.46M	+5.14M	+69.86%	$1.26	12.5M	Feb 19, 2023	See Notes	F1, F2
transaction	NUVB	Class A Common Stock	Purchase	$159K	+117K	+0.94%	$1.36	12.6M	Feb 20, 2023	See Notes	F1, F2
transaction	NUVB	Class A Common Stock	Purchase	$72.1K	+53K	+0.42%	$1.36	12.7M	Feb 21, 2023	See Notes	F1, F2
holding	NUVB	Class A Common Stock						1.17M	Feb 19, 2023	See Notes	F1, F3
holding	NUVB	Class A Common Stock						3.17M	Feb 19, 2023	See Notes	F1, F4
holding	NUVB	Class A Common Stock						2.2M	Feb 19, 2023	See Notes	F1, F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	EcoR1 Capital, LLC ("EcoR1") is the investment adviser to EcoR1 Capital Fund, L.P. ("Capital Fund"), EcoR1 Capital Fund Qualified, L.P. ("Qualified Fund") and EcoR1 Venture Opportunity Fund, L.P. ("Venture Fund"). EcoR1 is the general partner of Capital Fund and Qualified Fund, and Biotech Opportunity GP, LLC ("Biotech") is the general partner of Venture Fund. Mr. Nodelman is the manager and controlling owner of EcoR1 and Biotech. The funds hold these securities directly for the benefit of their investors. EcoR1 indirectly beneficially owns them as the investment adviser to the funds. Mr. Nodelman indirectly beneficially owns them as the control person of EcoR1. The reporting persons disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein.
F2	Qualified Fund is the record holder of these securities.
F3	Capital Fund is the record holder of these securities.
F4	EcoR1 Panacea Holdings, LLC, which is the owner of record of these securities, is managed by its managing members, Capital Fund, Qualified Fund and Venture Fund. Each of the reporting persons may be deemed a beneficial owner of shares held by EcoR1 Panacea Holdings, LLC but each reporting person disclaims beneficial ownership of any such shares except to the extent of its respective pecuniary interest therein.
F5	These securities are held of record by Venture Fund. Biotech indirectly beneficially owns these securities as the general partner of Venture Fund, and Mr. Nodelman indirectly beneficially owns these securities as the control person of Biotech and EcoR1.